Methylene blue encephalopathy: A case report and review of published cases

AANA Journal

Volumn 81, Issue 3, 2013, Pages 215-221

  Shopes, Ellen ^a   Gerard, Wayne ^a   Baughman, Jessica ^b  

^a Building 2   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Methylene blue; Parathyroidectomy; Postoperative encephalopathy; Serotonin syndrome

Indexed keywords

ATENOLOL; CALCIUM; CARBAMAZEPINE; GABAPENTIN; GALLIUM; GLUCOSE; INSULIN; LAMOTRIGINE; LEVOTHYROXINE SODIUM; LITHIUM; LORAZEPAM; METHYLENE BLUE; OXYBUTYNIN; PARATHYROID HORMONE; POTASSIUM; SIMVASTATIN; SODIUM; VERAPAMIL;

ADULT; AGITATION; ARTICLE; BEDTIME DOSAGE; BIPOLAR DISORDER; BLADDER IRRITATION; BODY MASS; BODY TEMPERATURE; BRAIN DISEASE; CALCIUM BLOOD LEVEL; CASE REPORT; CONSCIOUSNESS DISORDER; DISORIENTATION; DRUG WITHDRAWAL; ELECTIVE SURGERY; ELECTROLYTE DISTURBANCE; FEMALE; GASTROESOPHAGEAL REFLUX; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INTENSIVE CARE UNIT; LETHARGY; MEDICAL HISTORY; METHYLENE BLUE ENCEPHALOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PATIENT SAFETY; PATIENT TRANSPORT; PHYSIOTHERAPY; POLLAKISURIA; POTASSIUM BLOOD LEVEL; PREOPERATIVE EVALUATION; RADICULAR PAIN; RECOVERY ROOM; RESPIRATORY TRACT INTUBATION; SODIUM BLOOD LEVEL; SPEECH DISORDER; TRACHEOSTOMY; VERTEBRAL CANAL STENOSIS;

BRAIN DISEASES, METABOLIC; ENZYME INHIBITORS; FEMALE; HUMANS; METHYLENE BLUE; MIDDLE AGED; PARATHYROIDECTOMY; POSTOPERATIVE COMPLICATIONS; SEROTONIN SYNDROME;

EID: 84881524244     PISSN: 00946354     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Ng BKW, Cameron AJD. The role of methylene blue in serotonin syndrome: a systematic review. Psychosomatics. 2010;51(3):194-200.
2. Kozaki A, Watanabe J. Dose dependency of apparent volumes of distribution for methylene blue in rabbits. J Pharmacobiodynamics. 1981;4(1):49-57. doi:10.1248/bpb1978.4.49.
3. Khan MAS, North AP, Chadwick DR. Prolonged postoperative altered mental status after methylene blue infusion during parathyroidectomy: a case report and review of the literature. Ann R Coll Surg Engl. 2007;89(2):W9-W11. doi:10.1308/147870807X160434.
4. Ng BKW, Cameron AJ, Liang R, Rahman H. Serotonin syndrome following methylene blue infusion during parathyroidectomy: a case report and literature review [French]. Can J Anaesth. 2008;55(1):36-41. doi:10.1007/BF03017595.
5. Peter C, Hongwan D, Küpfer A, Lauterburg BH. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol. 2000;56(3):247-250. doi:10.1007/s002280000124.
6. Vutskits L, Briner A, Klauser P, et al. Adverse effects of methylene blue on the central nervous system. Anesthesiology. 2008;108(4):684-692.
7. Majithia A, Stearns MP. Methylene blue toxicity following infusion to localize parathyroid adenoma. J Laryngol Otol. 2006;120(2):138-140. doi:10.1017/S0022215105005098.
8. Martindale SJ, Stedeford JC. Neurological sequelae following methylene blue injection for parathyroidectomy. Anaesthesia. 2003;58(10):1041-1042. doi:10.1046/j.1365-2044.2003.03415_23.x.
9. Drug Safety Communication: Serious CNS reactions possible when given to patients taking certain psychiatric medications. Rockville, MD: Food and Drug Administration; July 26, 2011. Updated October 20, 2011. http://www.fda.gov/Drugs/DrugSafety/ucm263190.htm. Accessed March 7, 2013.
10. Kartha SS, Chacko CE, Bumpous JM, Fleming M, Lentsch EJ, Flynn MB. Toxic metabolic encephalopathy after parathyroidectomy with methylene blue localization. Otolaryngol Head Neck Surg. 2006;135(5):765-768. doi:10.1016/j.otohns.2006.05.026.
11. Patel AS, Singh-Ranger D, Lowery KA, Crinnion JN. Letter to the editor: adverse neurologic effect of methylene blue used during parathyroidectomy. Head Neck. 2006;28(6):567-568. doi:10.1002/hed.20416.
12. Aminoff M, ed. Neurology and General Medicine. Philadelphia, PA: Churchill Livingstone/ Elsevier; 2008:1106.
13. Rowley M, Riutort K, Shapiro D, Casler J, Festic E, Freeman WD. Methylene blue-associated serotonin syndrome: a 'green' encephalopathy after parathyroidectomy. Neurocrit Care. 2009;11(1):88-93. doi:10.1007/s12028-009-9206-z.
14. Mathew S, Linhartova L, Raghuraman G. Hyperpyrexia and prolonged postoperative disorientation following methylene blue infusion during parathyroidectomy. Anaesthesia. 2006;61(6):580-583. doi:10.1111/j.1365-2044.2006.04619.x.
15. Sweet G, Standiford SB. Methylene-blue-associated encephalopathy. J Am Coll Surg. 2007;204(3):454-458. doi:10.1016/j.jamcollsurg. 2006.12.030.
16. Oz M, Lorke DE, Hasan M, Petroianu GA. Cellular and molecular actions of methylene blue in the nervous system. Med Res Rev. 2011; 31(1):93-117. doi:10.1002/med.20177.
17. Dagtekin O, Marcus H, Müller C, Böttiger BW, Spöhr F. Lipid therapy for serotonin syndrome after intoxication with venlafaxine, lamotrigine and diazepam. Minerva Anestesiol. 2011;77(1):93-95.
18. Murphy GM, Hollander SB, Rodrigues HE, Kremer C, Schatzberg AF. Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression. Arch Gen Psychiatry. 2004;61(11):1163-1169. doi:10.1001/archpsyc.61.11.1163.
19. Stanford SC, Stanford BJ. Reply to JL Palmer. Postoperative delirium indicating an adverse drug reaction involving selective serotonin reuptake inhibitor, paroxetine?. J Psychopharmacol. 2000;14(2):186-187. doi:10.1177/026988110001400210.
20. Stanford SC, Stanford BJ, Gillman PK. Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of postoperative delirium. J Psychopharmacol. 2010;24(10):1433-1438. doi:10.1177/0269881109105450.
21. Dvir Y, Smallwood P. Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry. 2008;30(3):284-287. doi:10.1016/j.genhosppsych.2007.09.007.
22. Stanford BJ, Stanford SC. Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine? J Psychopharmacol. 1999;13(3):313-317. doi:10.1177/026988119901300322.
23. Bach KK, Lindsay FW, Berg LS, Howard RS. Prolonged postoperative disorientation after methylene blue infusion during parathyroidectomy. Anesth Analg. 2004;99(5):1573-1574.
24. Khavandi A, Whitaker J, Gonna H. Serotonin toxicity precipitated by concomitant use of citalopram and methylene blue. Med J Aust. 2008;189(9):534-535.
25. Pollack G, Pollack A, Delfiner J, Fernandez J. Parathyroid surgery and methylene blue: a review with guidelines for safe intraoperative use. Laryngoscope. 2009;119(10):1941-1946. doi:10.1002/lary.20581.
26. Héritier Barras A, Walder B, Seeck M. Serotonin syndrome following methylene blue infusion: a rare complication of antidepressant therapy. J Neurol Neurosurg Psychiatry. 2010;81(12):1421-1422. doi: 10.1136/jnnp.2009.172221.
27. Mihai R, Mitchell EW, Warwick J. Dose-response and postoperative confusion following methylene blue infusion during parathyroidectomy. Can J Anaesth. 2007;54(1):79-81. doi:10.1007/BF03021907.